Today: 19 July 2026
Browse Category

LSE:AZN 27 June 2025 - 25 December 2025

For live price, interactive charts, financials and the latest market data, visit Google Finance.
United Kingdom Stock Market Today: FTSE 100 Holiday Pause, BP Castrol Deal and 2026 Outlook (25 Dec 2025)

United Kingdom Stock Market Today: FTSE 100 Holiday Pause, BP Castrol Deal and 2026 Outlook (25 Dec 2025)

London — Thursday, 25 December 2025. The United Kingdom stock market is closed today for Christmas Day, putting a temporary pause on trading after a holiday-shortened run into the break. With the London Stock Exchange also shut on Friday for Boxing Day, the next meaningful read on UK risk appetite will come when markets reopen after the long weekend. MoneyWeek
25 December 2025
····
UK Stock Market Outlook: What to Know Before the FTSE 100 Opens on Monday 8 December 2025

UK Stock Market Outlook: What to Know Before the FTSE 100 Opens on Monday 8 December 2025

The UK stock market heads into Monday’s open with the FTSE 100 sitting just below the 9,700 mark, energy and bank stocks under pressure, and a brand‑new consumer giant — The Magnum Ice Cream Company — about to start trading in London. Add in a looming US Federal Reserve rate decision, key UK GDP data later this week, and an ongoing reshuffle of FTSE constituents, and Monday’s session is set up to be busy even before the opening auction finishes.
7 December 2025
·············
UK Stock Market Opening Preview, 5 December 2025: FTSE 100, BoE Cut Bets, Construction Slump and US Data in Focus

UK Stock Market Opening Preview, 5 December 2025: FTSE 100, BoE Cut Bets, Construction Slump and US Data in Focus

UK equities head into the final trading day of the week with the FTSE 100 hovering just below record territory, but sentiment is split between weak domestic data, growing expectations of Bank of England rate cuts, and a heavy US data calendar later today.
4 December 2025
···········
AstraZeneca (AZN) Share Price: What to Know Before London Market Opens on 17 November 2025

AstraZeneca (AZN) Share Price: What to Know Before London Market Opens on 17 November 2025

As the London Stock Exchange reopens on Monday, 17 November 2025, AstraZeneca PLC is one of the most important stocks to watch. The pharma giant has just delivered forecast‑beating Q3 results, hit fresh record highs, secured shareholder backing for an upgraded New York listing and kept its drug pipeline buzzing with new data and approvals – all while navigating political noise on drug pricing in both the US and UK. Cision News+3Reuters+3Reuters+3
16 November 2025
·
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

FTSE 100 Nears 10,000 as SSE Jumps on £33bn Grid Plan; Rate‑Cut Bets Lift Sentiment

LONDON — 12 November 2025. London’s blue‑chip FTSE 100 came within a whisker of the 10,000 mark on Wednesday, touching an intraday record around 9,928 before easing into the close at 9,887.40, a day after notching its highest ever finish. Tuesday’s record close at 9,899.60 followed weaker UK labour data that reinforced expectations the Bank of England could trim rates in December. reuters.com+2investing.com+2
12 November 2025
·····
Nasdaq Climbs Record Highs Then Retreats Amid Trade and Tech News

Nasdaq Surges 1.7% on Monday After Trump Calms Trade War Fears – Tech Stocks Lead Wild Comeback

Monday’s session saw a sharp recovery in equities after Friday’s selloff. The Nasdaq Composite rebounded to 22,513.52 at the close, up 1.39% for the dayinvesting.com. The tech-heavy Nasdaq-100 also climbed to 24,697.77, up 1.97%investing.com. These gains came as U.S. futures jumped and major tech names surged. By comparison, on Friday Oct 10 the Nasdaq Composite had plunged to 22,204.43investing.com on news of fresh trade tensions – wiping out nearly two weeks of gains. The broader S&P 500 fell 2.7% and the Dow lost 1.90%reuters.com. In all, Wall Street finished Oct 10 with declines of ~2–3% across the major indexes.
13 October 2025
·········
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca PLC is a leading Anglo-Swedish pharmaceutical giant specializing in oncology, respiratory, cardiovascular/metabolic, and rare disease medicinesmarketbeat.comastrazeneca.com. Headquartered in Cambridge, UK, it maintains primary listings on the London Stock Exchange and Nasdaq Stockholm, with secondary ADR trading in the U.S.astrazeneca.com. The company was formed in 1999 by merging Sweden’s Astra AB and the UK’s Zeneca. Its 2024 revenues were $54.07 billionastrazeneca.com, driven by top-selling drugs like Tagrisso, Lynparza, Farxiga, and Symbicortmarketbeat.com. In its 2024 Annual Report, AZN describes itself as “a global, science-led, patient-focused pharmaceutical business” and targets $80B in sales by 2030 with at least 20 new drugs launchedastrazeneca.comastrazeneca.com. Current Chair Michel Demaré and CEO Sir Pascal Soriot lead a company with roughly 70–80,000 employees worldwide, strategic R&D hubs in the US, UK, Sweden, China and emerging cell/gene therapy centers.
11 October 2025
···
European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

European markets closed the first day of the week with small gains. The pan‑European STOXX 600 edged up 0.18% to 555.53 aa.com.tr. Germany’s DAX 40 barely budged to 23,745.06 aa.com.tr, while Britain’s FTSE 100 added 0.16% to 9,299.84 aa.com.tr. France’s CAC 40 rose 0.13% to 7,880.87. By contrast, Italy’s FTSE MIB and Spain’s IBEX 35 both fell about 0.22% on the day aa.com.tr. Across the Atlantic, U.S. stock futures were little changed, reflecting caution ahead of key U.S. developments.
30 September 2025
······
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

European equities seesawed over the two days, buffeted by transatlantic trade tensions and shifting rate expectations. On Thursday Sept. 25, the STOXX Europe 600 index dropped 0.7%, touching levels not seen in three weeks reuters.com. Almost every major bourse closed in the red reuters.com as traders digested a slew of worrying signals: fresh U.S. trade investigations into high-tech imports, surprisingly robust U.S. economic data, and guarded comments from central bankers. By Friday Sept. 26, however, markets regained footing – the STOXX 600 ticked up roughly +0.3% by midday reuters.com and was on track to finish the eventful week slightly higher brecorder.com. The late-week relief came as investors pivoted to bargain-hunting in financial and industrial shares and awaited key U.S. inflation data for clues on interest rates reuters.com.
26 September 2025
········
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

The first half of 2025 has seen biotechnology and health technology sectors accelerate on multiple fronts, from groundbreaking scientific advances to robust deal-making. Industry optimism is high – a Deloitte survey of 150 life science executives found 75% believe 2025 will be a strong year, citing anticipated revenue growth and rapid innovation genengnews.com. This optimism is translating into action, with emerging technologies like gene editing, precision medicine, digital health, and AI reaching new milestones. Meanwhile, global market projections remain bullish: for example, the AI in healthcare market is projected to grow about 10-fold from ~$15 billion in 2024 to over $164 billion by 2030 globenewswire.com, and the digital health market is expected to soar past $1 trillion by the early 2030s precedenceresearch.com.
27 June 2025
···········
1 2
Go toTop